NCT06807996 is a NA clinical trial of Zinc-enriched yeast capsule in Elevated Blood Glucose, sponsored by Zhilei Shan.

Who is sponsoring NCT06807996?

NCT06807996 is sponsored by Zhilei Shan.

What drugs are being tested in NCT06807996?

Interventions in NCT06807996: Zinc-enriched yeast capsule, Edible yeast placebo capsule.

What condition does NCT06807996 study?

NCT06807996 studies Elevated Blood Glucose.

Is NCT06807996 still recruiting?

NCT06807996 is currently not yet recruiting. Last updated 14 May 2025.

Last reviewed 2025-05-14 · How we verify

NCT06807996

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Zinc Supplementation on Patients With Elevated Glycemic Status

Not yet recruiting NA Last updated 14 May 2025

What this trial tests

NA trial testing Zinc-enriched yeast capsule in Elevated Blood Glucose in 124 participants. Not yet recruiting.

Timeline

1 July 2025

Primary endpoint
1 December 2025

1 December 2025

Quick facts

Lead sponsor	Zhilei Shan
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	124
Start date	1 July 2025
Primary completion	1 December 2025
Estimated completion	1 December 2025

Drugs / interventions tested

Zinc-enriched yeast capsule
Edible yeast placebo capsule

Conditions studied

Elevated Blood Glucose — all drugs for Elevated Blood Glucose →

Sponsor

Zhilei Shan

Who can join

18 and older, any sex, with Elevated Blood Glucose. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this randomized, double-blind, placebo-controlled study included patients with elevated glycemic status is to investigate whether zinc supplementation (4mg per day) has beneficial effects on controlling blood glucose.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06807996 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zhilei Shan
Last refreshed: 14 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06807996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing